600196.SS vs BAJFINANCE.NS — which is stronger right now?
Same dated snapshot (2026-09-01): 600196.SS quality —/100 vs BAJFINANCE.NS —/100; engine LONG vs LONG. The comparison below is computed, dated, and auditable — not an opinion.
| Snapshot | 2026-09-01 · source: tencent | |
|---|---|---|
| 600196.SS (Fosun Pharma) | BAJFINANCE.NS (Bajaj Finance) | |
| Market / sector | ashare · Pharma | in · NBFC |
| Price | ¥22.84 | ₹1,088 |
| Quality score | —/100 | —/100 |
| Engine signal | LONG · 38 bars · uPnL -3.6% | LONG · 52 bars · uPnL +13.3% |
| Total return | -1.8% | -17.5% |
Thesis-break template (Pharma)
flagship drug losing exclusivity; pivotal trial failure; pricing-policy shifts; payer consolidation
Cite this page
Balance Labs Research Desk (2026-09-01). "600196.SS vs BAJFINANCE.NS — which is stronger right now?." balancelabs.app · https://balancelabs.app/stocks/compare/600196.ss-vs-bajfinance.ns · CC BY 4.0
Ask anything
Ask AI: 600196.SS vs BAJFINANCE.NS?What breaks the 600196.SS thesis?What breaks the BAJFINANCE.NS thesis?
30 free credits monthly · no card required · research support, not advice
← compare hub · snapshot 2026-09-01 · not investment advice